BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11171510)

  • 1. [Scintigraphy with somatostatin receptors in metastatic insulinoma].
    Delgado M; Razola P; Abós MD; García F; Prats E; Banzo J
    Rev Esp Med Nucl; 2000 Dec; 19(7):505-6. PubMed ID: 11171510
    [No Abstract]   [Full Text] [Related]  

  • 2. An endocrine active insulinoma with extended lymphogenic dissemination.
    Bökenkamp R; Duchateau CS; Stokkel MP
    Clin Nucl Med; 2003 Apr; 28(4):316-7. PubMed ID: 12642713
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatobiliary and Pancreatic: Tumor to tumor metastasis from a primary insulinoma to a hepatic adenoma.
    Xu X; Cong L; Zhao Y
    J Gastroenterol Hepatol; 2019 Mar; 34(3):489. PubMed ID: 30191606
    [No Abstract]   [Full Text] [Related]  

  • 4. Images of interest. Hepatobiliary and pancreatic: Insulinoma metastases with focal hepatic steatosis.
    Sumiyoshi S; Kobayashi Y; Souda K; Takehara Y; Nakamura H
    J Gastroenterol Hepatol; 2005 Apr; 20(4):650. PubMed ID: 15836720
    [No Abstract]   [Full Text] [Related]  

  • 5. [Receptor scintigraphy in endocrine gastrointestinal and pancreatic tumors].
    Joseph K; Stapp J; Reinecke J; Höffken H; Benning R; Neuhaus C; Trautmann ME; Schwerk WB; Arnold R
    Dtsch Med Wochenschr; 1992 Jun; 117(26):1025-8. PubMed ID: 1352234
    [No Abstract]   [Full Text] [Related]  

  • 6. Malignant Pancreatic Insulinoma with Large Hepatic Metastasis.
    Gojwari TA; Ilyas M; Dar MA; Malik AH; Kazimi MJA
    Am J Med; 2019 Mar; 132(3):e512-e513. PubMed ID: 30503878
    [No Abstract]   [Full Text] [Related]  

  • 7. The value of somatostatin-receptor scintigraphy in newly diagnosed endocrine gastroenteropancreatic tumors.
    Kisker O; Bartsch D; Weinel RJ; Joseph K; Welcke UH; Zaraca F; Rothmund M
    J Am Coll Surg; 1997 May; 184(5):487-92. PubMed ID: 9145069
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Metastatic liver disease].
    Privezentseva TV
    Vestn Rentgenol Radiol; 1985; (4):78-80. PubMed ID: 3000065
    [No Abstract]   [Full Text] [Related]  

  • 9. Intra-arterial liver chemotherapy and hormone therapy in malignant insulinoma: case report and review of the literature.
    Moscetti L; Saltarelli R; Giuliani R; Fornarini G; Bezzi M; Cortesi E
    Tumori; 2000; 86(6):475-9. PubMed ID: 11218190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Somatostatin receptor scintigraphy and endoscopic ultrasound for the diagnosis of insulinoma and gastrinoma].
    Zimmer T; Stölzel U; Liehr RM; Bäder M; Fett U; Hamm B; Wiedenmann B; Riecken EO
    Dtsch Med Wochenschr; 1995 Jan; 120(4):87-93. PubMed ID: 7835241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete clinical remission and disappearance of liver metastases after treatment with somatostatin analogue in a 40-year-old woman with a malignant insulinoma positive for somatostatin receptors type 2.
    Romeo S; Milione M; Gatti A; Fallarino M; Corleto V; Morano S; Baroni MG
    Horm Res; 2006; 65(3):120-5. PubMed ID: 16479142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metastatic pancreatic insulinoma with treatment-limiting thrombocytopenia.
    Nguyen AH; Donahue TR
    Am Surg; 2013 Mar; 79(3):E124-6. PubMed ID: 23461938
    [No Abstract]   [Full Text] [Related]  

  • 14. Malignant insulinoma: permanent hepatic artery embolization of liver metastases--preliminary results.
    Winkelbauer FW; Nierderle B; Graf O; Prokesch R; Thurnher S; Wildling R; Lammer J
    Cardiovasc Intervent Radiol; 1995; 18(6):353-9. PubMed ID: 8591620
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor induced local fibrogenic effect by hepatic metastasis of insulinoma.
    Longerich T; Ketterer K; Helmke BM; Friess H; Schirmacher P
    Virchows Arch; 2005 Jun; 446(6):680-1. PubMed ID: 15902484
    [No Abstract]   [Full Text] [Related]  

  • 16. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant insulinoma in childhood.
    Karachaliou F; Vlachopapadopoulou E; Kaldrymidis P; Simatos G; Zacharea M; Spanidou-Karvouni E; Michalacos S; Voros D
    J Pediatr Endocrinol Metab; 2006 May; 19(5):757-60. PubMed ID: 16789643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [111In-pentetreotide in the study of tumors expressing somatostatin receptors].
    Mateos Fernández J; Pons Pons F; Fuster Pelfort D; Vidal-Sicart S; Lomeña Caballero F; Herranz García-Romero R
    Rev Esp Med Nucl; 1999 Oct; 18(5):325-30. PubMed ID: 10562660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy].
    Carnaille B
    Ann Chir; 2000 Jul; 125(6):595-6. PubMed ID: 10986776
    [No Abstract]   [Full Text] [Related]  

  • 20. Unexpected Steatotic Liver Lesions.
    De Vito C; Rubbia-Brandt L; Toso C
    Gastroenterology; 2016 Jul; 151(1):32-3. PubMed ID: 27240321
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.